共 174 条
[1]
Natoli JL(2010)Global prevalence of chronic migraine: a systematic review Cephalalgia 30 599-609
[2]
Manack A(2007)Migraine comorbidity constellations Headache 47 857-865
[3]
Dean B(2016)Chronic daily headache: ten steps for primary care providers to regain control Headache 56 1675-1684
[4]
Butler Q(2005)Predictors of a negative response to topiramate therapy in patients with chronic migraine Headache 45 932-935
[5]
Turkel CC(2017)Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial Lancet Neurol 16 425-434
[6]
Stovner L(2017)Fremanezumab for the preventive treatment of chronic migraine N Engl J Med 377 2113-2122
[7]
Lipton RB(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-803
[8]
Tietjen GE(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-814
[9]
Herial NA(2010)OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Headache 50 921-936
[10]
Hardgrove J(2011)OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program Headache 51 1358-1373